Profitelligence Profitelligence · Filing Ledger Open IQV research →

Form 8-K · Current Report · Filed 2026-06-04

IQVIA Announces Pricing of Senior Notes Offering

On June 4, 2026, IQVIA Holdings Inc. announced that its subsidiary, IQVIA Inc., priced an offering of €950,000,000 in senior notes due 2033, bearing interest at a rate of 4.625% per annum. The proceeds will be used to refinance existing debt and cover offering-related fees. The issuance is expected to occur on or about June 11, 2026, subject to customary closing conditions.

Filer
Iqvia Holdings Inc. IQV · NYSE
Filed
Accession
0001193125-26-257730
CIK
0001478242
Signal
Medium impactHealthcare

Items reported

Item events

Reported Item

New Debt Issued Financial Instrument Agreement

Market reaction

Close before filing

$182.05

Next session

+0.8%

Since filing

+29.1%

Latest close

$235.02

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from IQV reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, IQV insiders reported 8 Form 4 transactions — net buying of $285K.

Full IQV insider history →

About Iqvia Holdings Inc.

Iqvia Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and contract research services. Its primary function is to support the healthcare sector by offering data-driven insights and innovations that underpin strategic decision-making across pharmaceutical, biotechnology, and medical device industries. Iqvia plays a crucial role in facilitating drug development through its comprehensive clinical research capabilities, encompassing everything from clinical trials to regulatory submissions. Additionally, its technology solutions leverage artificial intelligence and machine learning to optimize clinical and commercial operations, contributing to enhanced patient outcomes and streamlined healthcare delivery. Iqvia's integrated services impact sectors such as drug safety, patient engagement, and real-world evidence, making it an indispensable partner for healthcare companies seeking to navigate complex markets and regulatory environments. Globally recognized for its vast data repository and cutting-edge analytical platforms, Iqvia serves as a pivotal player in the transformation of the healthcare landscape, empowering organizations to accelerate innovation and improve patient care.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another IQV filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts